PA
ONSIZ

Perceptive Advisors’s Oncobiologics, Inc. Series B Warrant ONSIZ Stock Holding History

Perceptive Advisors’s Portfolio ONSIZ Stock Details ONSIZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-462,500
Closed -$42K – 171
2017
Q2 		$42K Hold
462,500
– – ﹤0.01% 125
2017
Q1 		$231K Sell
462,500
-193,882
-30% -$83.9K 0.01% 133
2016
Q4 		$518K Hold
656,382
– – 0.04% 116
2016
Q3 		$787K Buy
656,382
+193,882
+42% +$141K 0.05% 101
2016
Q2 		$202K Buy
+462,500
New +$243K 0.01% 145

Other funds holding ONSIZ

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Perceptive Advisors's ONSIZ Position: Q3 2017 in Review

Perceptive Advisors sold out of Oncobiologics, Inc. Series B Warrant (ONSIZ) in Q3 2017, closing a stake of 462,500 shares — an estimated $42K sold.

Perceptive Advisors first reported a position in ONSIZ in Q2 2016 and held it in 5 quarters. The position peaked at $787K in Q3 2016. 10 funds tracked by Wall St. Rank hold ONSIZ as of Q3 2017.

  • Perceptive Advisors reported no remaining Oncobiologics, Inc. Series B Warrant position as of Q3 2017 after selling out during the quarter.
  • Perceptive Advisors sold 462,500 Oncobiologics, Inc. Series B Warrant shares in Q3 2017, an estimated $42K.
  • Perceptive Advisors first reported a position in Oncobiologics, Inc. Series B Warrant in Q2 2016 and held it in 5 quarters.
  • Perceptive Advisors's Oncobiologics, Inc. Series B Warrant position peaked at $787K in Q3 2016.
  • 10 funds tracked by Wall St. Rank held Oncobiologics, Inc. Series B Warrant as of Q3 2017.

Based on Perceptive Advisors's 13F filing for Q3 2017, filed 14 Nov 2017.